Fidelity Investments’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $150M | Buy |
31,955,637
+7,267,528
| +29% | +$36.9M | 0.01% | 991 |
|
|
2025
Q4 | $105M | Buy |
24,688,109
+9,291,909
| +60% | +$35.3M | 0.01% | 1157 |
|
|
2025
Q3 | $49.1M | Buy |
15,396,200
+6,157,332
| +67% | +$13.9M | ﹤0.01% | 1443 |
|
|
2025
Q2 | $21M | Buy |
9,238,868
+9,130,557
| +8,430% | +$14.7M | ﹤0.01% | 1680 |
|
|
2025
Q1 | $68.9K | Sell |
108,311
-198,472
| -65% | -$154K | ﹤0.01% | 3715 |
|
|
2024
Q4 | $316K | Buy |
306,783
+22,476
| +8% | +$24.2K | ﹤0.01% | 3087 |
|
|
2024
Q3 | $335K | Buy |
284,307
+41,949
| +17% | +$53.3K | ﹤0.01% | 3010 |
|
|
2024
Q2 | $296K | Buy |
242,358
+59,281
| +32% | +$118K | ﹤0.01% | 2903 |
|
|
2024
Q1 | $399K | Sell |
183,077
-382,247
| -68% | -$706K | ﹤0.01% | 2802 |
|
|
2023
Q4 | $876K | Sell |
565,324
-142,644
| -20% | -$188K | ﹤0.01% | 2513 |
|
|
2023
Q3 | $913K | Sell |
707,968
-19,412
| -3% | -$30.6K | ﹤0.01% | 2475 |
|
|
2023
Q2 | $1.25M | Buy |
727,380
+21,683
| +3% | +$36K | ﹤0.01% | 2438 |
|
|
2023
Q1 | $1.07M | Sell |
705,697
-10,949
| -2% | -$24.7K | ﹤0.01% | 2510 |
|
|
2022
Q4 | $1.15M | Buy |
716,646
+15,074
| +2% | +$22.3K | ﹤0.01% | 2505 |
|
|
2022
Q3 | $1.02M | Sell |
701,572
-1,637
| -0.2% | -$2.52K | ﹤0.01% | 2605 |
|
|
2022
Q2 | $1.29M | Buy |
703,209
+1,392
| +0.2% | +$2.67K | ﹤0.01% | 2615 |
|
|
2022
Q1 | $1.87M | Buy |
701,817
+165,382
| +31% | +$635K | ﹤0.01% | 2629 |
|
|
2021
Q4 | $2.32M | Sell |
536,435
-509,185
| -49% | -$2.98M | ﹤0.01% | 2532 |
|
|
2021
Q3 | $5.32M | Hold |
1,045,620
| – | – | ﹤0.01% | 2348 |
|
|
2021
Q2 | $6.62M | Buy |
1,045,620
+13
| +0% | +$101 | ﹤0.01% | 2251 |
|
|
2021
Q1 | $8.08M | Hold |
1,045,607
| – | – | ﹤0.01% | 2110 |
|
|
2020
Q4 | $6.85M | Buy |
1,045,607
+220,700
| +27% | +$1.58M | ﹤0.01% | 2099 |
|
|
2020
Q3 | $5.49M | Sell |
824,907
-4,066
| -0.5% | -$30.2K | ﹤0.01% | 2039 |
|
|
2020
Q2 | $6.91M | Buy |
828,973
+360
| +0% | +$3.34K | ﹤0.01% | 1947 |
|
|
2020
Q1 | $6.36M | Sell |
828,613
-5
| -0% | -$35 | ﹤0.01% | 1848 |
|
|
2019
Q4 | $6.88M | Sell |
828,618
-56,108
| -6% | -$379K | ﹤0.01% | 1970 |
|
|
2019
Q3 | $6.53M | Sell |
884,726
-438,485
| -33% | -$4.33M | ﹤0.01% | 1969 |
|
|
2019
Q2 | $14.8M | Sell |
1,323,211
-815,568
| -38% | -$8.55M | ﹤0.01% | 1739 |
|
|
2019
Q1 | $23M | Sell |
2,138,779
-3,785,652
| -64% | -$56M | ﹤0.01% | 1548 |
|
|
2018
Q4 | $89.5M | Sell |
5,924,431
-820,122
| -12% | -$12.2M | 0.01% | 902 |
|
|
2018
Q3 | $125M | Buy |
6,744,553
+900,927
| +15% | +$20.5M | 0.01% | 859 |
|
|
2018
Q2 | $134M | Buy |
5,843,626
+51,953
| +0.9% | +$1.33M | 0.02% | 819 |
|
|
2018
Q1 | $165M | Buy |
5,791,673
+30,379
| +0.5% | +$867K | 0.02% | 762 |
|
|
2017
Q4 | $122M | Buy |
5,761,294
+231,189
| +4% | +$4.79M | 0.01% | 906 |
|
|
2017
Q3 | $100M | Buy |
5,530,105
+17,646
| +0.3% | +$275K | 0.01% | 974 |
|
|
2017
Q2 | $85.4M | Buy |
5,512,459
+34,732
| +0.6% | +$524K | 0.01% | 1058 |
|
|
2017
Q1 | $94.6M | Buy |
5,477,727
+17,375
| +0.3% | +$229K | 0.01% | 1014 |
|
|
2016
Q4 | $60M | Buy |
5,460,352
+17,090
| +0.3% | +$207K | 0.01% | 1213 |
|
|
2016
Q3 | $85.3M | Buy |
5,443,262
+30,097
| +0.6% | +$364K | 0.01% | 1052 |
|
|
2016
Q2 | $55.3M | Buy |
5,413,165
+1,484
| +0% | +$16.9K | 0.01% | 1233 |
|
|
2016
Q1 | $69.8M | Buy |
5,411,681
+8,038
| +0.1% | +$112K | 0.01% | 1118 |
|
|
2015
Q4 | $113M | Buy |
+5,403,643
| New | +$85.5M | 0.02% | 918 |
|
Other funds holding CTMX
KCM
PA
VA
VCM
BBA